Correlation Between Akero Therapeutics and IVERIC Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and IVERIC Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and IVERIC Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and IVERIC Bio, you can compare the effects of market volatilities on Akero Therapeutics and IVERIC Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of IVERIC Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and IVERIC Bio.

Diversification Opportunities for Akero Therapeutics and IVERIC Bio

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Akero and IVERIC is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and IVERIC Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IVERIC Bio and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with IVERIC Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IVERIC Bio has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and IVERIC Bio go up and down completely randomly.

Pair Corralation between Akero Therapeutics and IVERIC Bio

Given the investment horizon of 90 days Akero Therapeutics is expected to generate 8.86 times less return on investment than IVERIC Bio. In addition to that, Akero Therapeutics is 1.33 times more volatile than IVERIC Bio. It trades about 0.02 of its total potential returns per unit of risk. IVERIC Bio is currently generating about 0.19 per unit of volatility. If you would invest  1,897  in IVERIC Bio on August 31, 2024 and sell it today you would earn a total of  2,098  from holding IVERIC Bio or generate 110.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy26.57%
ValuesDaily Returns

Akero Therapeutics  vs.  IVERIC Bio

 Performance 
       Timeline  
Akero Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Akero Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Akero Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
IVERIC Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days IVERIC Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, IVERIC Bio is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Akero Therapeutics and IVERIC Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akero Therapeutics and IVERIC Bio

The main advantage of trading using opposite Akero Therapeutics and IVERIC Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, IVERIC Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IVERIC Bio will offset losses from the drop in IVERIC Bio's long position.
The idea behind Akero Therapeutics and IVERIC Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume